gene	geneRole	proteinEffect	event	source	sourceEvent	sourceUrls	treatment	sourceRelevantTreatmentApproaches	relevantTreatmentApproaches	applicableCancerType	applicableDoid	blacklistCancerTypes	level	direction	evidenceUrls
ALK	ONCO	GAIN_OF_FUNCTION	FUSION	VICC_CGI	fusion	http	Crizotinib			Lung Adenocarcinoma	X		A	RESPONSIVE	https
BRCA1	TSG	LOSS_OF_FUNCTION	INACTIVATION	VICC_CGI	inact	http	DRUP			Solid Tumors	X	Hematologic cancer;2531	B	RESPONSIVE	http
ERBB2	ONCO	GAIN_OF_FUNCTION	AMPLIFICATION	VICC_CGI	amp	http	Trastuzumab			Breast Cancer	X		A	RESPONSIVE	http
ERBB2	ONCO	UNKNOWN	AMPLIFICATION	VICC_CGI	amp	http	Panitumumab			Colorectal Cancer	X		B	RESISTANT	http
FGFR2	ONCO	UNKNOWN	FUSION	VICC_CGI	fusion	http	Erdafitinib			Bladder Cancer	X		B	RESPONSIVE
MET	ONCO	GAIN_OF_FUNCTION	AMPLIFICATION	VICC_CGI	amp	http	DRUP			Advanced Solid Tumor	X	Hematologic cancer;2531	B	RESPONSIVE
NRAS	ONCO	UNKNOWN	ACTIVATION	VICC_CGI	act	http	Cetuximab			Colorectal Cancer	X		A	RESISTANT	http